Graham Capital Management, L.P. Terns Pharmaceuticals, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 32,109 shares of TERN stock, worth $239,212. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,109
Previous 30,231
6.21%
Holding current value
$239,212
Previous $198,000
10.1%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TERN
# of Institutions
139Shares Held
63.8MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$56.8 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$46.1 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$45.4 Million1.36% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.95MShares$36.9 Million3.41% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$30.7 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $280M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...